Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Harmony Biosciences Holdings (HRMY) Asset Utilization Ratio (2020 - 2025)

Historic Asset Utilization Ratio for Harmony Biosciences Holdings (HRMY) over the last 6 years, with Q3 2025 value amounting to 0.71.

  • Harmony Biosciences Holdings' Asset Utilization Ratio fell 657.36% to 0.71 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.71, marking a year-over-year decrease of 657.36%. This contributed to the annual value of 0.79 for FY2024, which is 73.73% up from last year.
  • According to the latest figures from Q3 2025, Harmony Biosciences Holdings' Asset Utilization Ratio is 0.71, which was down 657.36% from 0.71 recorded in Q2 2025.
  • Over the past 5 years, Harmony Biosciences Holdings' Asset Utilization Ratio peaked at 0.77 during Q2 2024, and registered a low of 0.52 during Q1 2021.
  • Over the past 5 years, Harmony Biosciences Holdings' median Asset Utilization Ratio value was 0.72 (recorded in 2021), while the average stood at 0.71.
  • Its Asset Utilization Ratio has fluctuated over the past 5 years, first surged by 7326.22% in 2021, then tumbled by 1027.41% in 2022.
  • Over the past 5 years, Harmony Biosciences Holdings' Asset Utilization Ratio (Quarter) stood at 0.74 in 2021, then fell by 10.27% to 0.66 in 2022, then increased by 10.19% to 0.73 in 2023, then increased by 1.26% to 0.74 in 2024, then dropped by 3.84% to 0.71 in 2025.
  • Its Asset Utilization Ratio stands at 0.71 for Q3 2025, versus 0.71 for Q2 2025 and 0.73 for Q1 2025.